Integra LifeSciences Holdings Gross Margin 2010-2024 | IART

Current and historical gross margin for Integra LifeSciences Holdings (IART) over the last 10 years. The current gross profit margin for Integra LifeSciences Holdings as of September 30, 2024 is %.
Integra LifeSciences Holdings Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-09-30 $1.57B $0.86B 54.89%
2024-06-30 $1.57B $0.88B 56.00%
2024-03-31 $1.53B $0.86B 56.12%
2023-12-31 $1.54B $0.88B 57.37%
2023-09-30 $1.54B $0.91B 58.88%
2023-06-30 $1.55B $0.93B 60.00%
2023-03-31 $1.56B $0.97B 62.04%
2022-12-31 $1.56B $0.97B 62.26%
2022-09-30 $1.57B $0.97B 61.88%
2022-06-30 $1.57B $0.97B 62.12%
2022-03-31 $1.56B $0.96B 61.79%
2021-12-31 $1.54B $0.94B 61.18%
2021-09-30 $1.53B $0.94B 61.40%
2021-06-30 $1.51B $0.93B 61.63%
2021-03-31 $1.38B $0.84B 61.25%
2020-12-31 $1.37B $0.85B 62.03%
2020-09-30 $1.38B $0.86B 62.05%
2020-06-30 $1.39B $0.86B 61.72%
2020-03-31 $1.51B $0.94B 62.37%
2019-12-31 $1.52B $0.95B 62.78%
2019-09-30 $1.51B $0.94B 62.68%
2019-06-30 $1.49B $0.93B 62.36%
2019-03-31 $1.48B $0.92B 62.37%
2018-12-31 $1.47B $0.90B 61.28%
2018-09-30 $1.46B $0.89B 60.70%
2018-06-30 $1.37B $0.84B 61.20%
2018-03-31 $1.29B $0.79B 61.62%
2017-12-31 $1.19B $0.75B 63.25%
2017-09-30 $1.08B $0.70B 65.24%
2017-06-30 $1.05B $0.69B 65.52%
2017-03-31 $1.01B $0.66B 65.38%
2016-12-31 $0.99B $0.64B 64.82%
2016-09-30 $0.98B $0.62B 63.87%
2016-06-30 $0.95B $0.60B 63.27%
2016-03-31 $0.92B $0.58B 63.25%
2015-12-31 $0.88B $0.56B 62.85%
2015-09-30 $0.80B $0.50B 62.52%
2015-06-30 $0.77B $0.48B 62.71%
2015-03-31 $0.79B $0.49B 62.17%
2014-12-31 $0.80B $0.49B 61.98%
2014-09-30 $0.73B $0.45B 61.52%
2014-06-30 $0.74B $0.45B 61.22%
2014-03-31 $0.72B $0.43B 60.56%
2013-12-31 $0.70B $0.42B 59.83%
2013-09-30 $0.83B $0.51B 60.84%
2013-06-30 $0.83B $0.51B 61.06%
2013-03-31 $0.83B $0.51B 61.73%
2012-12-31 $0.83B $0.52B 62.41%
2012-09-30 $0.82B $0.51B 61.71%
2012-06-30 $0.81B $0.50B 61.45%
2012-03-31 $0.80B $0.49B 61.26%
2011-12-31 $0.78B $0.48B 61.67%
2011-09-30 $0.77B $0.48B 62.73%
2011-06-30 $0.76B $0.48B 63.05%
2011-03-31 $0.74B $0.47B 63.43%
2010-12-31 $0.73B $0.46B 63.17%
2010-09-30 $0.72B $0.46B 63.62%
2010-06-30 $0.71B $0.45B 63.84%
2010-03-31 $0.70B $0.44B 63.88%
2009-12-31 $0.68B $0.44B 64.13%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.918B $1.542B
Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $219.781B 26.81
Intuitive Surgical (ISRG) United States $217.430B 113.68
Alcon (ALC) Switzerland $43.790B 29.30
Edwards Lifesciences (EW) United States $40.720B 25.86
IQVIA Holdings (IQV) United States $37.284B 20.54
IDEXX Laboratories (IDXX) United States $35.259B 41.52
DexCom (DXCM) United States $34.017B 51.23
Waters (WAT) United States $24.246B 35.85
STERIS (STE) Ireland $21.575B 24.84
SONOVA HOLDING (SONVY) Switzerland $20.893B 0.00
Hologic (HOLX) United States $16.069B 17.45
Fresenius Medical Care AG KGaA (FMS) Germany $13.597B 13.96
Globus Medical (GMED) United States $12.707B 32.18
Sysmex ADR (SSMXY) Japan $11.852B 37.16
Penumbra (PEN) United States $10.587B 103.70
Masimo (MASI) United States $9.271B 44.86
Glaukos (GKOS) United States $8.829B 0.00
Teleflex (TFX) United States $8.395B 13.39
Integer Holdings (ITGR) United States $4.744B 26.89
Inari Medical (NARI) United States $4.650B 0.00
PROCEPT BioRobotics (PRCT) United States $3.570B 0.00
Veracyte (VCYT) United States $3.336B 100.12
LivaNova (LIVN) United Kingdom $2.642B 15.25
Nihon Kohden (NHNKY) Japan $2.325B 17.66
Tandem Diabetes Care (TNDM) United States $2.299B 0.00
Elekta AB (EKTAY) Sweden $2.235B 20.10
TransMedics (TMDX) United States $2.080B 65.93
Alphatec Holdings (ATEC) United States $1.614B 0.00
Artivion (AORT) United States $1.290B 85.50
RxSight (RXST) United States $1.286B 0.00
Pulse Biosciences (PLSE) United States $1.152B 0.00
OPKO Health (OPK) United States $1.003B 0.00
Paragon 28 (FNA) United States $0.979B 0.00
AxoGen (AXGN) United States $0.831B 0.00
Mesa Laboratories (MLAB) United States $0.787B 18.55
IRadimed (IRMD) United States $0.752B 40.63
AVANOS MEDICAL, INC (AVNS) United States $0.729B 12.39
ORTHOFIX MEDICAL INC (OFIX) United States $0.702B 0.00
SiBone (SIBN) United States $0.698B 0.00
OrthoPediatrics (KIDS) United States $0.657B 0.00
Treace Medical Concepts (TMCI) United States $0.587B 0.00
Semler Scientific (SMLR) United States $0.576B 30.30
Pacific Biosciences Of California (PACB) United States $0.496B 0.00
ClearPoint Neuro (CLPT) United States $0.494B 0.00
AngioDynamics (ANGO) United States $0.488B 0.00
Delcath Systems (DCTH) United States $0.486B 0.00
NeuroPace (NPCE) United States $0.419B 0.00
CVRx (CVRX) United States $0.418B 0.00
Tactile Systems Technology (TCMD) United States $0.417B 22.57
Alpha Tau Medical (DRTS) Israel $0.279B 0.00
Inogen (INGN) United States $0.258B 0.00
Accuray (ARAY) United States $0.229B 0.00
Anteris Technologies Global (AVR) Australia $0.215B 0.00
KORU Medical Systems (KRMD) United States $0.187B 0.00
Nevro (NVRO) United States $0.184B 0.00
Sight Sciences (SGHT) United States $0.146B 0.00
Atossa Genetics (ATOS) United States $0.120B 0.00
Sensus Healthcare (SRTS) United States $0.115B 12.26
Monogram Orthopaedics (MGRM) United States $0.098B 0.00
908 Devices (MASS) United States $0.098B 0.00
LENSAR (LNSR) United States $0.097B 0.00
Spectral Diagnostics (EDTXF) Canada $0.097B 0.00
EDAP TMS S.A (EDAP) France $0.084B 0.00
Vicarious Surgical (RBOT) United States $0.083B 0.00
WORK Medical Technology Group (WOK) China $0.076B 0.00
InspireMD (NSPR) Israel $0.072B 0.00
Neuronetics (STIM) United States $0.071B 0.00
Hyperfine (HYPR) United States $0.068B 0.00
EnVVeno Medical (NVNO) United States $0.062B 0.00
Rapid Micro Biosystems (RPID) United States $0.061B 0.00
Covalon Technologies (CVALF) Canada $0.059B 30.86
Lucid Diagnostics (LUCD) United States $0.049B 0.00
Baird Medical Investment Holdings (BDMD) $0.046B 0.00
Microbot Medical (MBOT) United States $0.040B 0.00
Spectral AI (MDAI) United States $0.038B 0.00
Precision Optics (POCI) United States $0.032B 0.00
Envoy Medical (COCH) United States $0.031B 0.00
Accelerate Diagnostics (AXDX) United States $0.028B 0.00
DarioHealth (DRIO) United States $0.026B 0.00
NexGel (NXGL) United States $0.022B 0.00
Biosig Technologies (BSGM) United States $0.020B 0.00
Ekso Bionics Holdings (EKSO) United States $0.014B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.014B 0.00
QT Imaging Holdings (QTI) United States $0.014B 0.00
Adagio Medical Holdings (ADGM) United States $0.012B 0.00
Check-Cap (CHEK) Israel $0.008B 0.00
Aspira Women's Health (AWH) United States $0.007B 0.00
PAVmed (PAVM) United States $0.007B 0.00
Tenon Medical (TNON) United States $0.006B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
T2 Biosystems (TTOO) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00